Modificación de los niveles excretados por orina de angiotensina II y angiotensina-(1-7) en pacientes con estenosis aórtica grave o crítica, sometidos a reemplazo valvular aórtico

de la Vega, César Lopez; Rosas, Martín; Pastelín, Gustavo; Lomelí C, Catalina; del Valle, Leonardo.
Rev. guatem. cardiol. (Impresa) ; 22(1): 20-33, ene.-jun. 2012. tab
Artigo em Espanhol | LILACS | ID: biblio-869880

Documentos relacionados

  1. Machine learning approaches to predict the 1-year-after-initial-AMI survival of elderly patients.
  2. TAVI and the future of aortic valve replacement.
  3. Impact of early initiation of renin-angiotensin blockade on renal function and clinical outcomes in patients with hypertensive emergency: a retrospective cohort study.
  4. A critical review of wire injury induced aortic valve stenosis in mice.
  5. Association of Renin-Angiotensin-Aldosterone Inhibitors with COVID-19 Infection and Disease Severity among Individuals with Hypertension.
  6. Circulating Monocyte Subsets and Transcatheter Aortic Valve Replacement.
  7. The use of angiotensin system inhibitors correlates with longer survival in resected pancreatic adenocarcinoma patients.
  8. [ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH DEGENERATIVE AORTIC VALVE STENOSIS: THE STATE-OF-THE-ART].
  9. [Degenerative Aortic Stenosis: Modern View on Development, Course, and Management].
  10. Diabetes Mellitus and Its Implications in Aortic Stenosis Patients.